ETMR-11. A CASE OF PRIMARY DIFFUSE LEPTOMENINGEAL PRIMITIVE NEUROECTODERMAL TUMOR. (4th December 2020)

• Record Type: Journal Article
• Authors: Sugawa, Masahiro; Terashima, Keita; Matsukawa, Yukihiro; Mizuno, Takanori; Isshiki, Kyohei; Tsujimoto, Shinichi; Uchiyama, Meri; Sakamoto, Kenichi; Gocho, Yoshihiro; Osumi, Tomoo; Shioda, Yoko; Kiyotani, Chikako; Kato, Motohiro; Tomizawa, Daisuke; Usami, Kenichi; Ogiwara, Hideki; Tsutsumi, Yoshiaki; Nakano, Masayuki; Yoshioka, Takako; Matsumoto, Kimikazu
• Is Part Of: Neuro-oncology. Volume 22(2020)Supplement 3
• Page Start: iii325
• Page End: iii325
• Publication Date: 2020-12-04
• Subjects: Brain Neoplasms -- Periodicals; Brain -- Tumors -- Periodicals; Brain -- Cancer -- Periodicals; Nervous system -- Cancer -- Periodicals; 616.99481
• DOI: 10.1093/neuonc/noaa222.215
• Languages: English
• ISSNs: 1522-8517

Abstract

Abstract: BACKGROUND: Primary diffuse leptomeningeal primitive neuroectodermal tumor (PDL PNET) is a rare embryonal brain tumor which arises primarily in the meninges without an intraparenchymal mass. Few previous reports of this condition exist, and the clinical outcomes are poor. We herein report a case of a child with PDL PNET and present a cursory review of the literature. CASE: A 3-year-old female patient was seen at a local clinic due to vomiting, headaches, and seizures. As a head MRI revealed hydrocephalus but no mass, acute encephalopathy was initially diagnosed. She received steroid pulse therapy, but the symptoms progressed to hallucination and lethargy. Another MRI at the 1-month follow-up revealed diffuse leptomeningeal enhancement. Thereafter she was transferred to our hospital. A spine MRI revealed spinal dissemination. She underwent a dura mater biopsy, and the pathological analysis led to the diagnosis of PDL PNET. She received chemotherapy consisting of vincristine, cyclophosphamide, etoposide, cisplatin, and intrathecal methotrexate injections two months after the initial presentation. The progressive hydrocephalus was managed with external ventricular drainage. Two weeks after the first cycle of chemotherapy the hydrocephalus resolved, and the external ventricular drainage was removed. A follow-up MRI showed that the leptomeningeal enhancement decreased during the four cycles of chemotherapy without radiotherapy. The patient is scheduled to receive high-dose chemotherapy as consolidation therapy. CONCLUSION: PDL PNET is extremely rare, and its diagnosis is often delayed. Treatment of PDL PNET is very difficult due to its aggressive course, and surgical resection is impossible. Early diagnosis may help improve outcomes.